In this study, we identify that ABCC2 is a direct target of METTL3, and find that PTX and CBP can up-regulate ABCC2 expression in cytomembrane, which may contribute to the resistance of NSCLC cells to PTX or CBP. Here, ABCC2 is linked to non-small cell lung carcinoma.